https://www.selleckchem.com/products/brd3308.html
mandatory generic prescribing and generic substitution by pharmacists are needed. The study findings show that PMBJP's unbranded generics offer great opportunities for substantial cost savings. But, in order to fully realise the potential of this scheme, some policy actions are urgently required. First, the PMBJP drug list must include all essential drugs that feature in NLEM. Second, BPPI should procure only those drugs that pass the bioequivalence test. Third, compulsory de-branding of generics should be done in a phased manner. Fourt
Curtir
Comentario
Compartilhar
